Article Versions Notes

Jäger N, Hoffmann M, Pöhlmann S, Krüger N. Nafamostat-Mediated Inhibition of SARS-CoV-2 Ribosomal Frameshifting Is Insufficient to Impair Viral Replication in Vero Cells. Comment on Munshi et al. Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses. Viruses 2022, 14, 177. Viruses. 2022; 14(7):1526. https://doi.org/10.3390/v14071526

Jäger, Niklas, Markus Hoffmann, Stefan Pöhlmann, and Nadine Krüger. 2022. "Nafamostat-Mediated Inhibition of SARS-CoV-2 Ribosomal Frameshifting Is Insufficient to Impair Viral Replication in Vero Cells. Comment on Munshi et al. Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses. Viruses 2022, 14, 177" Viruses 14, no. 7: 1526. https://doi.org/10.3390/v14071526

Jäger, N., Hoffmann, M., Pöhlmann, S., & Krüger, N. (2022). Nafamostat-Mediated Inhibition of SARS-CoV-2 Ribosomal Frameshifting Is Insufficient to Impair Viral Replication in Vero Cells. Comment on Munshi et al. Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses. Viruses 2022, 14, 177. Viruses, 14(7), 1526. https://doi.org/10.3390/v14071526